#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15530	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2146	719.9	0	.	n	.	0	A69G	SNP	69	69	A	296	296	G	826	G,A,T	402,349,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15530	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2146	719.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1411	1411	C	991	C	897	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15530	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2146	719.9	0	HET	.	.	.	C1525T	.	1525	1525	C	1752	1752	C	798	C,T	563,173	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15530	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2146	719.9	0	HET	.	.	.	T1412TGGGGG,TGGGGGG	.	1412	1412	T	1639	1639	T	934	TGGGGG,TGGGGGG	642,185	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28886	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3645	790.7	0	.	n	.	0	T695C	SNP	695	695	T	1089	1089	C	897	C,T	822,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28886	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3645	790.7	0	.	n	.	0	A1638G	SNP	1638	1638	A	2032	2032	G	931	G,A	876,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28886	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3645	790.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2365	2365	C	889	C	813	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28886	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3645	790.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2439	2439	A	932	A	871	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28886	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3645	790.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2991	2991	C	875	C	813	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2234	folP	855	855	100.0	folP.l15.c30.ctg.1	1595	139.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1076	1078	AGC	239;238;238	A;G,A;C	221;220,1;222	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6012	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3277	182.7	1	SNP	p	S91F	1	.	.	271	273	TTC	547	549	TTC	198;194;195	T;T;C	183;179;179	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6012	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3277	182.7	1	SNP	p	D95G	1	.	.	283	285	GGC	559	561	GGC	190;188;190	G;G;C	175;172;175	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6012	gyrA	2751	2751	99.85	gyrA.l6.c17.ctg.1	3277	182.7	1	SNP	p	G95N	0	.	.	283	285	GGC	559	561	GGC	190;188;190	G;G;C	175;172;175	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1700	mtrR	633	633	99.84	mtrR.l15.c17.ctg.1	1329	127.5	0	.	p	.	0	F184L	NONSYN	550	552	TTC	861	863	TTG	210;210;212	T;T;G	196;196;196	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1700	mtrR	633	633	99.84	mtrR.l15.c17.ctg.1	1329	127.5	1	SNP	p	G45D	0	.	.	133	135	GGC	444	446	GGC	221;221;223	G;G;C	204;204;205	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	884	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1102	80.1	0	.	n	.	0	A197.	DEL	197	197	A	614	614	A	221	A	208	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5598	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2897	192.5	1	SNP	p	D86N	0	.	.	256	258	GAC	541	543	GAC	245;247;249	G;A;C	235;232;238	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5598	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2897	192.5	1	SNP	p	R87I	0	.	.	259	261	CGT	544	546	CGT	252;249;249	C;G;T	240;237;233	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5598	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2897	192.5	1	SNP	p	R87W	0	.	.	259	261	CGT	544	546	CGT	252;249;249	C;G;T	240;237;233	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5598	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2897	192.5	1	SNP	p	S87R	1	.	.	259	261	CGT	544	546	CGT	252;249;249	C;G;T	240;237;233	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5598	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2897	192.5	1	SNP	p	S88P	0	.	.	262	264	TCC	547	549	TCC	248;249;252	T;C;C	235;237;238	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4758	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2565	184.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1491	1493	GGC	213;211;209	G;G;C	189;186;188	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4272	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2247	188.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1156	1158	GCA	235;235;234	G;C;A	216;218;219	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4272	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2247	188.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1159	1161	ATC	233;237;238	A;T;C	216;220;221	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4272	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2247	188.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1171	1173	GTG	224;224;224	G;T;G	205;208;208	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4272	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2247	188.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1171	1173	GTG	224;224;224	G;T;G	205;208;208	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4272	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2247	188.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1675	1677	ACC	215;215;215	A;C;C	198;201;198	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4272	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2247	188.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1729	1731	GCG	217;217;219	G;C;G	193;165;184	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4272	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2247	188.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1729	1731	GCG	217;217;219	G;C;G	193;165;184	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4272	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2247	188.9	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1852	1854	AGC	208;207;207	A,G;G;C	194,1;194;193	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4272	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2247	188.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1861	1863	GGC	203;196;197	G;G;C	190;184;183	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4272	penA	1752	1752	100.0	penA.l15.c17.ctg.1	2247	188.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1879	1881	CCG	173;173;171	C,G;C,G;G	126,8;129,1;128	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6072	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3034	199.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1666	1668	CCG	197;197;196	C;C;G	172;176;171	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2680	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1785	149.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	485	485	C	174	C,A	158,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2718	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1476	183.0	0	.	p	.	0	N38E	NONSYN	112	114	AAT	397	399	GAA	259;259;260	G;A;A	240;241;242	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2718	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1476	183.0	0	.	p	.	0	N134D	NONSYN	400	402	AAT	685	687	GAT	262;256;255	G;A;T	241;237;235	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2718	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1476	183.0	0	.	p	.	0	P175S	NONSYN	523	525	CCA	808	810	TCA	234;234;236	T;C;A	217;217;221	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2718	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1476	183.0	0	.	p	.	0	A218V	NONSYN	652	654	GCC	937	939	GTC	229;229;226	G;T;C	217;214;213	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2718	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1476	183.0	0	.	p	.	0	F222Y	NONSYN	664	666	TTT	949	951	TAT	219;220;219	T;A;T	202;205;203	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2718	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1476	183.0	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1267	1269	GCA	207;209;207	G;C;A	184;187;185	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2718	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1476	183.0	1	SNP	p	G120K	1	.	.	358	360	AAG	643	645	AAG	257;263;261	A;A;G	236;242;241	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2718	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1476	183.0	1	SNP	p	A121D	1	.	.	361	363	GAC	646	648	GAC	259;258;255	G,A;A;C	238,1;240;239	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2718	porB1b	1047	1047	99.14	porB1b.l15.c4.ctg.1	1476	183.0	1	SNP	p	D121N	0	.	.	361	363	GAC	646	648	GAC	259;258;255	G,A;A;C	238,1;240;239	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10620	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4919	215.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1110	rpsJ	312	312	100.0	rpsJ.l6.c17.ctg.1	979	112.4	1	SNP	p	V57M	1	.	.	169	171	ATG	531	533	ATG	220;227;224	A;T;G,A	204;207;205,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
